GRI Bio
7 hedge funds and large institutions have $14.7K invested in GRI Bio in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
95% less capital invested
Capital invested by funds: $277K → $14.7K (-$262K)
Holders
7
Holding in Top 10
–
Calls
–
Puts
–
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Geode Capital Management
Boston,
Massachusetts
| $5.72K |
|
|||
2
Vanguard Group
Malvern,
Pennsylvania
| $4.2K |
|
|||
|
SG
3
StoneX Group
New York
| $4.01K |
|
|||
|
TRCT
4
Tower Research Capital (TRC)
New York
| $704 |
|
|||
5
BlackRock
New York
| $52 |
|
|||
|
SS
6
SBI Securities
Tokyo,
Japan
| $29 |
|
|||
7
Bank of America
Charlotte,
North Carolina
| $5 |
|
|||
|
DS
8
DRW Securities
Chicago,
Illinois
| – |
|
|||
9
UBS Group
Zurich,
Switzerland
| – |
|